Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn Starr

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
British Journal of Pharmacology|December 24, 2016
Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulatorSimon E Ward, Paul Beswick, Novella Calcinaghi, et al.
Lancet (London, England)|May 23, 2015
Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trialRobert Pickard, Kathryn Starr, Graeme MacLennan, et al.
Health Technology Assessment (Winchester, England)|August 6, 2015
Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)Robert Pickard, Kathryn Starr, Graeme MacLennan, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
British Journal of Pharmacology|December 24, 2016
Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulatorSimon E Ward, Paul Beswick, Novella Calcinaghi, et al.
Lancet (London, England)|May 23, 2015
Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trialRobert Pickard, Kathryn Starr, Graeme MacLennan, et al.
Health Technology Assessment (Winchester, England)|August 6, 2015
Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)Robert Pickard, Kathryn Starr, Graeme MacLennan, et al.
Pageof 2